COMPOSITIONS SOUS FORME D'UNE SOLUTION AQUEUSE INJECTABLE COMPRENANT AU MOINS UNE INSULINE HUMAINE A21G ET UN SUPPRESSEUR DE GLUCAGON A ACTION PRANDIALE

European patent · EP4019039 · In force

Register entry

Publication number
EP4019039
Application number
EP22156880
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 27, 2018
Published
Jun 29, 2022
Granted
Oct 11, 2023
Protection ends at the latest
Jul 26, 2038
Next annual fee due
Jul 31, 2027
IPC classes
A61K 38/26 (2006.01)
A61K 38/28 (2006.01)
A61K 45/06 (2006.01)
A61K 47/02 (2006.01)
A61K 9/08 (2006.01)
A61K 31/198 (2006.01)
C07K 14/62 (2006.01)
A61P 3/10 (2006.01)
A61P 5/48 (2006.01)
Priority
FR 1757172 27.07.2017
FR 1757184 28.07.2017
FR 1855250 14.06.2018
Filing language
French
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 21, 2024

    Change

    Published in Swissreg on 21.08.2024

  4. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  5. Jan 8, 2024

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 08.01.2024

  6. Oct 11, 2023

    Granted

    Published in Swissreg on 11.10.2023

Parties

Holder

ADOCIA

Adocia

115, Avenue Lacassagne, 69003 Lyon, FR

Agent

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventor

CHAN, You-Ping

69360 TERNAY, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.